BPC-157
Other ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Synthetic pentadecapeptide marketed for tissue-repair claims. Current human evidence is extremely limited, and FDA flags compounded BPC-157 for limited route-specific safety data and peptide impurity/API characterization concerns.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This safety record covers a controlled, investigational, or otherwise out-of-scope substance. It remains available for reference, but it is not part of NutriStack's public supplement publication set.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
BPC-157 is an other most often used for no approved wellness use, human efficacy evidence is insufficient for consumer guidance, reference-only safety profile. NutriStack rates the overall evidence as insufficient. A typical adult dose is Not provided; NutriStack does not provide dosing guidance for research peptides., commonly taken as not supported for human use outside approved clinical research or regulated medical care. This profile indexes 2 sources.
- Unknown product purity, potency, and sterility risk outside regulated drug supply
- Injection-site reactions or infection risk with injectable products
- Immune reactions are possible with peptide impurities or aggregation
- Pregnancy or nursing
- History of cancer or active malignancy unless specifically cleared by an oncologist
The bottom line
Evidence rating insufficient. Most-documented uses: no approved wellness use, human efficacy evidence is insufficient for consumer guidance, reference-only safety profile. 2 sources indexed (2025–2026), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Preclinical literature proposes VEGF/nitric-oxide, Akt-eNOS, ERK1/2, angiogenesis, and anti-inflammatory signaling, but these mechanisms have not been validated in large human efficacy or safety trials.1
Dosing & protocol.
Route-specific guidance is intentionally not provided for unapproved research peptides.
Full safety detail.
Side effects
- Unknown product purity, potency, and sterility risk outside regulated drug supply
- Injection-site reactions or infection risk with injectable products
- Immune reactions are possible with peptide impurities or aggregation
Contraindications
- Pregnancy or nursing
- History of cancer or active malignancy unless specifically cleared by an oncologist
- Use by competitive athletes subject to anti-doping rules
- Use without clinician supervision
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Reviews & position papers
1- 1Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal HealingSource linkedPMIDMcGuire FP et al. · Curr Rev Musculoskelet Med · 2025
The review describes broad preclinical interest but extremely limited human data and calls for rigorous clinical trials.
Reference material
1- 2Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksSource linkedURLU.S. Food and Drug Administration · FDA · 2026
FDA flags compounded BPC-157 for immunogenicity risk, peptide impurity/API characterization complexity, and limited route-specific safety information.
Common questions.
Quick answers about BPC-157, drawn from the data on this page.
What is BPC-157?
Synthetic pentadecapeptide marketed for tissue-repair claims. Current human evidence is extremely limited, and FDA flags compounded BPC-157 for limited route-specific safety data and peptide impurity/API characterization concerns.
What is BPC-157 used for?
Commonly cited benefits of BPC-157 include: No approved wellness use; Human efficacy evidence is insufficient for consumer guidance; Reference-only safety profile. NutriStack rates the overall evidence as insufficient.
What is a typical dose of BPC-157?
A typical adult dose of BPC-157 is Not provided; NutriStack does not provide dosing guidance for research peptides.. The commonly recommended form is Not supported for human use outside approved clinical research or regulated medical care. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of BPC-157?
Reported side effects include unknown product purity, potency, and sterility risk outside regulated drug supply, injection-site reactions or infection risk with injectable products, immune reactions are possible with peptide impurities or aggregation. This is educational information; check with a healthcare professional before use.
How strong is the evidence for BPC-157?
NutriStack rates this as Insufficient, meaning the body of evidence reviewed in NutriStack's tiering framework. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
BPC-157 in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.